Zeta Cytokeratin 17 Antibody. Zeta’s mouse monoclonal antibody recognizes Cytokeratin 17, shows a peculiar localization in human epithelial appendages including hair follicles, which undergo a growth cycle throughout adult life.
The type I cytokeratin 17 (CK17) shows a peculiar localization in human epithelial appendages including hair follicles, which undergo a growth cycle throughout adult life. Additionally, CK17 is induced, along with CK6 and CK16, early after acute injury to human skin. Predominant expression of CK17and the frequent expression of CK8 and CK19, with little CK6/CK16 and CK1/CK10 expression are the characteristic features of basal cell carcinomas (BCC), suggesting that BCC is differentiated towards undifferentiated follicular epithelia, most probably hair bulge cells.
Zeta Corporation is a leader in recombinant monoclonal IVD antibodies for immunohistochemistry (IHC) offering 400+ tumor and tissue specific relevant products developed by a pathologist for pathologists. Visit Precision Recombinant Antibodies – IVD Antibodies – About Zeta Corporation (zeta-corp.com) to learn more about Zeta Corporation.